Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 203: | Line 203: | ||
[https://www.youtube.com/watch?v=EMqL23b03jU by Yale School of Public Health YouTube] | [https://www.youtube.com/watch?v=EMqL23b03jU by Yale School of Public Health YouTube] | ||
The world’s first malaria vaccines were recommended for general use only in October 2021, but already the parasites that cause the disease are developing resistance to them. “We currently have two malaria vaccines, which is really exciting, but they have modest efficacy that wanes over time,” said Dr. Amy Bei, PhD, an Associate Professor of Epidemiology at the Yale School of Public Health. Malaria killed just under 600,000 people in 2023. | The world’s first malaria vaccines were recommended for general use only in October 2021, but already the parasites that cause the disease are developing resistance to them. “We currently have two malaria vaccines, which is really exciting, but they have modest efficacy that wanes over time,” said Dr. Amy Bei, PhD, an Associate Professor of Epidemiology at the Yale School of Public Health. Malaria killed just under 600,000 people in 2023. | ||
=====35 years of RTS,S | The world’s first malaria vaccine for endemic countries===== | |||
[https://www.youtube.com/watch?v=HfCk4aF6dJY by GSK YouTube] | |||
Find how we worked with partners on the research and development of RTS,S – the world’s first malaria vaccine for endemic countries. The video features interviews with our GSK R&D teams, our partners at PATH and healthcare leaders in Kenya, to delve into 35 years of development: how we started out, what challenges we met along the way and where things are now. | |||
